CNBC October 23, 2024
Yet another study shows that blockbuster GLP-1 drugs may offer health benefits beyond diabetes and weight loss.
This time, more research is showing that they may significantly curb addictive behaviors.
Drugs such as Novo Nordisk‘s highly popular diabetes injection Ozempic can cut drug and alcohol abuse by around half, according to a new study published last week in the scientific journal Addiction. That suggests Ozempic and similar medications could potentially become a new treatment for opioid and alcohol use disorder.
“This study not only contributes to the evolving landscape of substance use therapy but also opens avenues for more comprehensive and effective treatment strategies for those affected by” the two disorders, the study authors wrote.
Here’s...
Today's Sponsors
Today's Sponsor